Don’t Trade in the Dark—Get Your Pre-Market Report Every Day.Join Now
Search stocks
Vishnu Chemicals Ltd

| Quarterly Financial Results Q3 FY 2025-26

NEUTRAL SENTIMENT

Report Source

⬤31st Jan 26

Summary : Vishnu Chemicals reported increased revenue and 9-month profit, with an unmodified auditor's review.

Quarterly Report Analysis & Insights

Financial Disclosures

  1. Consolidated Total Expenses for Q3 FY26: ₹37,393.93 Lakhs (vs Q3 FY25: ₹32,978.29 Lakhs).
  2. Consolidated Total Expenses for 9M FY26: ₹1,04,837.68 Lakhs (vs 9M FY25: ₹94,859.07 Lakhs).
  3. Standalone Total Expenses for Q3 FY26: ₹28,249.23 Lakhs (vs Q3 FY25: ₹25,334.97 Lakhs).
  4. Standalone Total Expenses for 9M FY26: ₹81,325.70 Lakhs (vs 9M FY25: ₹72,530.19 Lakhs).
  5. Consolidated Total Income for Q3 FY26: ₹41,751.20 Lakhs (vs Q3 FY25: ₹37,420.65 Lakhs).
  6. Consolidated Total Income for 9M FY26: ₹1,17,957.48 Lakhs (vs 9M FY25: ₹1,06,354.92 Lakhs).
  7. Consolidated Domestic Sales for Q3 FY26: ₹18,515.97 Lakhs.
  8. Consolidated Overseas Sales for Q3 FY26: ₹22,422.80 Lakhs.
  9. Standalone Total Income for Q3 FY26: ₹31,156.71 Lakhs (vs Q3 FY25: ₹28,346.01 Lakhs).
  10. Standalone Total Income for 9M FY26: ₹89,269.28 Lakhs (vs 9M FY25: ₹81,181.53 Lakhs).
  11. Both standalone and consolidated financial results are presented.
  12. Consolidated results include the Holding Company and its subsidiaries/step-down subsidiaries.
  13. Standalone results pertain only to Vishnu Chemicals Limited.

Corporate Overview

  1. Domestic
  2. Overseas
  3. Manufacture and sale of Specialty Chemicals.
  4. Formal and informative, disclosing board meeting outcome and financial results.
  5. Single reportable business segment: Specialty Chemicals.
  6. Two geographical revenue areas: Domestic and Overseas.

Risk Factors

  1. Slight dip in Q3 net profit.
  2. Fluctuations in inventory changes.
  3. Rising finance costs impact profitability.
  4. Dependency on raw material prices.

Key Drivers

  1. Revenue growth in Q3 and nine months.
  2. Increased overseas sales contribution.
  3. Unmodified auditor's review report.
  4. Focus on specialty chemicals segment.

Auditor’s Report

  1. Unmodified opinion on standalone financial results.
  2. Unmodified conclusion on consolidated financial results.

Corporate Governance

  1. Audit Committee reviewed the unaudited consolidated financial results.

Management Discussion & Analysis

Performance Drivers

  1. Increased revenue from operations.
  2. Growth in overseas sales.